Stay up to date with the latest developments from OpenBind – an initiative driving the future of structure-based drug design.
Explore our news, breakthroughs, and community updates as we accelerate innovation together.
March 2, 2026
OpenBind: delivering the UK’s AI for Science ambitions
The UK Government’s AI for Science Strategy and the UKRI AI Research and Innovation Strategic Framework set out an ambitious national agenda to accelerate discovery, strengthen global scientific leadership and translate AI‑enabled research into real‑world impact. The inclusion of OpenBind within these strategies reflects its role as a foundational capability helping to deliver this vision.
July 18, 2025
UK and France ministers back AI drug discovery at Diamond
The UK’s Parliamentary Under-Secretary of State at the Department of Science, Innovation and Technology, Feryal Clark, visited Diamond to gain insights into the groundbreaking work planned by the OpenBind consortium. An ambitious initiative that aims to revolutionise drug discovery through artificial intelligence. Feryal Clark, Parliamentary Under-Secretary of State for Science, Innovation and Technology, visited Diamond Light Source to learn about OpenBind – an AI-driven initiative set to transform drug discovery.
June 10, 2025
Diamond will host a pioneering AI-driven drug discovery consortium
Diamond will be the base for OpenBind, an AI-driven drug discovery centre which will make the UK a world-leader in drug innovation and advancement.
